Inactive Instrument

Press Releases Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Apr. 03	BU
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	BU
Xeris Biopharma: Q4 Earnings Snapshot	Mar. 06	AQ
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events	Mar. 06	BU
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital	Mar. 06	BU
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024	Feb. 28	BU
Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference	Feb. 05	BU
Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab	Jan. 10	BU
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Jan. 05	BU
Xeris Biopharma Updates Its Outlook for 2023	Jan. 04	BU
Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 27	BU
Xeris Biopharma CEO unveils game-changing drug innovations and record financial success	Nov. 17	AQ
Xeris Biopharma: Q3 Earnings Snapshot	Nov. 09	AQ
Xeris Biopharma Reports Third Quarter 2023 Financial Results	Nov. 09	BU
Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023	23-10-16	BU
Xeris Biopharma Announces Private Convertible Note Exchange Transactions	23-09-27	BU
Xeris to Participate in the 2023 Cantor Global Healthcare Conference	23-09-14	BU
Xeris to Participate at the H.C. Wainwright 25th Annual Global Investment Conference	23-08-28	BU
Xeris Biopharma CEO unveils record quarterly revenue, underpinned by unique business model	23-08-10	AQ
Xeris Biopharma: Q2 Earnings Snapshot	23-08-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Press Releases

Filters